Your Cart Item
Reports Within

Parameters

Reports Within:

Parameter Include:

Requisites
Measures

Number of red blood cells in the blood

Identifies

Red blood cell disorders

Measures: Number of red blood cells in the blood

Identifies: Red blood cell disorders

60
Mins

Homes

1M
Happy

Customers

4.9
Google

Rating

Certified

Labs

What is the maximum days the report can be obtained for the test

Maximum Days for Report Obtainment for ctDNA Hot Spot Mutations in 4 Genes Test

The report for the ctDNA Hot Spot Mutations in 4 Genes Test (EGFR, KRAS, NRAS, BRAF) can be obtained within 10-14 business days from the date of sample collection.

What are the prerequisites for the test ctDNA for Hot Spot Mutations in 4 Genes Test (EGFR, KRAS, NRAS, BRAF)

  • Patients must have a confirmed diagnosis of cancer
  • Patients must have a tissue biopsy available for comparison
  • Patients must not have received any treatment that could potentially affect the results of the test within the past 3 weeks
  • Patients must have a prescription from a healthcare provider for the test

What are the measure values for the test ctDNA for Hot Spot Mutations in 4 Genes Test (EGFR, KRAS, NRAS, BRAF)

  • EGFR: 0.01%
  • KRAS: 0.05%
  • NRAS: 0.03%
  • BRAF: 0.02%

What does this test ctDNA for Hot Spot Mutations in 4 Genes Test (EGFR, KRAS, NRAS, BRAF) identify?

Test for Hot Spot Mutations in 4 Genes (EGFR, KRAS, NRAS, BRAF)

The ctDNA test for Hot Spot Mutations in 4 Genes (EGFR, KRAS, NRAS, BRAF) identifies specific mutations in these genes that are known to be associated with various types of cancer. Here is detailed information on what each gene mutation can indicate:

  • EGFR: Mutations in the EGFR gene are commonly found in non-small cell lung cancer (NSCLC) and can indicate responsiveness to targeted therapies.
  • KRAS: Mutations in the KRAS gene are often associated with colorectal cancer and can influence the prognosis and treatment options for patients.
  • NRAS: Mutations in the NRAS gene are linked to melanoma and other types of cancer, impacting treatment decisions and outcomes.
  • BRAF: Mutations in the BRAF gene are prevalent in melanoma and certain types of colorectal cancer, affecting treatment responses and survival rates.

Why is this test ctDNA for Hot Spot Mutations in 4 Genes Test (EGFR, KRAS, NRAS, BRAF) taken?

CTDNA testing for Hot Spot Mutations in 4 Genes (EGFR, KRAS, NRAS, BRAF) is taken to help determine the presence of specific genetic mutations in cell-free DNA circulating in the bloodstream. These mutations are often associated with various types of cancer, particularly lung cancer and colorectal cancer.

By analyzing the presence of mutations in these genes, healthcare providers can better understand the underlying genetic drivers of a patient's cancer and tailor treatment plans accordingly. For example, certain mutations may indicate a patient's likelihood of responding to targeted therapies or immunotherapy.

Overall, ctDNA testing for Hot Spot Mutations in these 4 genes can provide valuable information for personalized cancer treatment strategies and monitoring disease progression.

No FAQs available.

Customer Google Rating